DSD-T212
Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T212
46,XY isolated 17,20-lyase deficiency caused by compound heterozygous CYB5A variants, with testicular microlithiasis.
Case fields and evidence
- Category
-
Congenital Adrenal Hyperplasia (CAH)
- Age
-
Neonatal onset, LC-MS/MS evaluation at age 17
- Sex
-
Male (46,XY, ambiguous genitalia at birth)
- Karyotype
-
46,XX
- Genetics
-
CYP17A1
- Phenotypes
-
Delayed puberty (HP:0000823)
- Diagnosis
-
46,XY isolated 17,20-lyase deficiency caused by compound heterozygous CYB5A variants, with testicular microlithiasis.
- Follow-up
-
At 3 months after discontinuation: testosterone 6.5 nmol/L, FSH 4.7 IU/L, LH 20.1 IU/L.
- General phenotype
-
Male phenotype; primary hypogonadism.
- Imaging
-
Testicular microlithiasis detected at 18 months of age; stable on ultrasound during childhood and puberty.
- Laboratory findings
-
Neonatal hCG stimulation: testosterone <0.3→1.0 nmol/L, androstenedione 0.6→0.8 nmol/L; FSH <0.3 IU/L, LH 1.0 IU/L; at age 17 LC-MS/MS showed testosterone 6.1 nmol/L, androstenedione <0.8 nmol/L, DHEAS 738 nmol/L, 17-OHP 30.8 nmol/L; MetHb 0.098 mmol/mmol Hb.
- Management
-
Testosterone therapy and hypospadias repair during infancy; intramuscular testosterone from age 13; replacement resumed at age 16 after gynecomastia developed following discontinuation.
- Pathology
-
Not reported in the original text (no testicular biopsy performed).
- Evidence level
-
See source
- Clinical history
-
See source
- Family history
-
See source
- Puberty / Tanner
-
See source
Cite this resource
DSD Research Library | Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T212 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T212?version=v1.4.0